Dimethylpolysiloxane vs Blue Dye 2: which is worse?

What is Dimethylpolysiloxane?

Dimethylpolysiloxane (PDMS, polydimethylsiloxane) is a silicone-based polymer used as an antifoaming agent in food and beverages. It prevents the formation of foam during food manufacturing and cooking. It is the same base material used in silicone cookware, medical devices, and contact lenses.

What is Blue Dye 2?

Blue Dye 2 (Indigotine/Indigo Carmine) is a synthetic disulfonated derivative of indigo. Unlike natural indigo from the indigo plant, the FD&C version is synthetically manufactured from petroleum. It produces a dark royal blue to indigo color and is used in food, pharmaceuticals, and medical diagnostics.

Documented risks

Dimethylpolysiloxane: Dimethylpolysiloxane is generally considered non-toxic. It is not absorbed by the gut and passes through the digestive system unchanged. The FDA permits it at up to 10 ppm in cooking oils. EFSA's evaluation found no evidence of toxicity at permitted food use levels. There are no established cancer or reproductive toxicity concerns with PDMS at food use concentrations. The compound is the same base polymer used in many safe medical applications including contact lenses and breast implants (though the medical grade is different purity). The main environmental concern is PDMS persistence in the environment, as it is not readily biodegradable. Primary consumer concern is psychological rather than toxicological: the fact that it is used in both McDonald's frying oil and Silly Putty (which also contains PDMS) generates public attention, but the chemistries are actually different grades of the same polymer family.

Blue Dye 2: Animal studies conducted in the 1980s found that high-dose Blue Dye 2 caused brain tumors in male rats. An NTP bioassay (1987) found statistically significant increases in brain gliomas (astrocytomas) in male rats given high doses. The FDA reviewed these findings and determined that the doses far exceeded typical human dietary exposure. Nonetheless, the tumor finding remains in the scientific record as a concerning data point. EFSA's 2010 safety evaluation of Indigo Carmine (E132) reached an unusual conclusion: it could not establish an ADI due to data limitations, including the brain tumor findings. This means EFSA adopted an implicit conservative position — it neither declared Blue 2 safe nor formally banned it, but the absence of an established ADI signals scientific uncertainty. In medical diagnostic use, high intravenous doses of Indigo Carmine can cause hypertension, bradycardia, and in rare cases anaphylaxis. These are dose-specific clinical pharmacological effects, not relevant to dietary consumption at food use levels. Blue 2 was not included in the 2007 Lancet hyperactivity study. Limited direct research links Blue 2 to behavioral effects. The FDA's April 2025 announcement includes Blue 2 in the class of petroleum-based synthetic dyes to be phased out of the US food supply, reflecting updated policy on the category rather than specific new Blue 2 toxicity data.